COVID-19 and heightened attention to racism affect American workers’ mental health and relationships

Morneau Shepell’s Mental Health Index™ improves slightly for July at a five-point decline from the pre-pandemic benchmark of 75

CHICAGO, Aug. 5, 2020 /PRNewswire/ – Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today released its monthly Mental Health Index™ report, making July the fourth consecutive month with a negative mental health score, as feelings of…

Morneau Shepell’s Mental Health Index™ improves slightly for July at a five-point decline from the pre-pandemic benchmark of 75

CHICAGO, Aug. 5, 2020 /PRNewswire/ – Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today released its monthly Mental Health Index™ report, making July the fourth consecutive month with a negative mental health score, as feelings of isolation and financial risk continuing to be the top drivers of American employees’ mental health. While mental stress has increased compared to the prior month, the steepness of the increase has, however, been flattening.

The Mental Health Index™ score for July is -5, which measures a decline in mental health from the pre-2020 benchmark of 75, but this month’s score is a one-point improvement from the previous month. The Mental Health Index™ also tracks sub-scores against the benchmark, measuring optimism (-8.0), anxiety (-6.4), depression (-6.1), work productivity (-5.5) and isolation (-4.8). Although the sub-scores remain low, all areas saw improvement in July except for optimism, which declined slightly when compared to last month.

«While parts of the United States started to open up for business in June, some markets have had to slow down their reopening plans. The Mental Health Index™ shows the continued negative impact the uncertainty surrounding the pandemic is having on American workers’ mental health and quality of life,» said Stephen Liptrap, president and chief executive officer. «As COVID-19 cases continue to rise again, workers are starting to lose their early optimism on rebounding from the pandemic and remain very concerned about a potential second mass shutdown, similar to what happened in March.»

Anxiety levels rising across many non-White demographics
When it comes to mental health differences by race, the Mental Health Index saw anxiety scores worsen for most people of color in June during the initial awareness and response to the killing of George Floyd. July showed some signs of improvement as the dialogue on racism continued and early indication of change began. In contrast, White respondents continued to show improvement in their mental health month over month, without the same decline in June.

Overall, 74 percent of individuals surveyed believe that racism is a problem in the United States, though only 17 percent believe that racism is a problem in their workplace. When considering the results by race, 90 percent of individuals identifying as Black strongly agree or agree that racism is a problem in the United States, while 73 percent of individuals identifying as White strongly agree or agree. When asked if racism is a problem in their workplace, 33 percent of individuals identifying as Black strongly agree or agree, and only 14 percent of individuals identifying as White strongly agree or agree.

Americans divided about systemic racism in society and the workplace
One of the major issues facing American society – systemic racism – has received heightened awareness as a result from the many protests held nationwide in response to the number of recent killings of Black Americans. As more Americans begin to give meaningful thought to this issue, their outlook varies. Thirty-five (35) percent of respondents feel that systemic racism is likely to decrease in the United States, 33 percent are unsure, and 31 percent feel that systemic racism is unlikely to decrease. When it comes to their workplace, 24 percent feel that it is likely that systemic racism will decrease, 37 percent are unsure, and 39 percent feel that systemic racism is unlikely to decrease.

Companies with smaller workforces at a mental health disadvantage
July’s report reflects a strong correlation between an individual’s scores on the Mental Health Index™ and the size of the company where they are employed. People who indicate working at companies with 51-100 employees have the lowest mental health scores (-8.2), while those who report working at companies with more than 10,000 employees have the highest mental health scores (-2.4). Sole proprietors (-3.4) and those who work for companies with 2-50 employees (-5.0) scored in the middle.

«While small businesses continue to be disproportionally impacted by the pandemic over large companies, once an organization reaches more than 50 workers, that close-knit familial sentiment felt by employees begins to strain, as managers need to supervise more workers and have less time to do so,» said Paula Allen, senior vice president of research, analytics and innovation. «The fact that employees at larger organizations scored better than average suggests that the benefits and programs that many larger organizations offer are having a positive effect. It’s critical for employers of all sizes to seek ways to support their people’s health and wellbeing, now more than ever. Employee assistance programs are much more cost effective than many small- to mid-size organizations realize and they offer support that can be life changing.»

The full U.S. report includes more insight on changes to mental stress, the impact of a positive outlook on one’s emotional state of mind and variations of the Mental Health Index score by demographics, industries and regions. The full U.S. report can be found at:  https://www.morneaushepell.com/permafiles/92897/mental-health-index-report-usa-july-2020.pdf.

About the Mental Health Index
The monthly survey by Morneau Shepell was conducted through an online survey in English from June 22 to June 30, 2020, with 5,000 respondents in the United States. All respondents reside in the United States and were employed within the last six months. The data has been statistically weighted to ensure the regional and gender composition of the sample reflect this population. The margins of error for the survey are +/- 3.2 percent, valid 19 times out of 20. The Mental Health Index™ is published monthly, beginning April 2020, and compares against benchmark data collected in 2017, 2018 and 2019.

About Morneau Shepell
Morneau Shepell is a leading provider of technology-enabled HR services that deliver an integrated approach to employee wellbeing through our cloud-based platform. Our focus is providing world-class solutions to our clients to support the mental, physical, social and financial wellbeing of their people. By improving lives, we improve business. Our approach spans services in employee and family assistance, health and wellness, recognition, pension and benefits administration, retirement consulting, actuarial and investment services. Morneau Shepell employs approximately 6,000 employees who work with some 24,000 client organizations that use our services in 162 countries. For more information, visit morneaushepell.com.

Cision View original content:http://www.prnewswire.com/news-releases/covid-19-and-heightened-attention-to-racism-affect-american-workers-mental-health-and-relationships-301106039.html

SOURCE Morneau Shepell Inc.

SPIRE Announces Advances in Construction of SPIRE Village

GENEVA, Ohio, Aug. 5, 2020 /PRNewswire-PRWeb/ — When Baltimore-based investment firm AXXELLA, LLC, a subsidiary of Blue Ocean, acquired SPIRE Institute and Academy in 2019, its strategic plan included expanding the mega-facility near Lake Erie in five major areas: athletics, academics, events, recreation and facilities. Construction of SPIRE Village is well underway, and the owners are continuing with their plans by upgrading resident…

GENEVA, Ohio, Aug. 5, 2020 /PRNewswire-PRWeb/ — When Baltimore-based investment firm AXXELLA, LLC, a subsidiary of Blue Ocean, acquired SPIRE Institute and Academy in 2019, its strategic plan included expanding the mega-facility near Lake Erie in five major areas: athletics, academics, events, recreation and facilities. Construction of SPIRE Village is well underway, and the owners are continuing with their plans by upgrading resident housing.

SPIRE Village consists of five 2,300 sq. ft. homes built specifically for SPIRE Academy student athletes, with each home having six bedrooms. Each bedroom accommodates two twin beds, a nightstand, wardrobe, two study tables with chairs and a shared six-drawer chest. The student lounge has a big screen TV, a couch, chairs and a dining room table with chairs for house meetings. There are three student bathrooms and a washer and dryer. Picnic tables and some outdoor sports equipment will be placed in between the houses.

Well insulated, outfitted with sprinkler systems and equipped with LED lighting, each house is heated by natural gas and is fully air conditioned. Each student room has its own unique entry key. All buildings are handicapped accessible.

A house parent who is fully trained in safety and COVID-19 precautions will occupy a one-bedroom apartment in each building, complete with kitchen, dining/living area and full bath. Residents will attend weekly meetings designed around personal growth topics jointly hosted by the house parent and a student who lives in the house. In addition to intra-Village competitions for fun and prizes, there will be activities planned where all houses work together on internal and external community projects.

«Everything we do at SPIRE is meant to help our students discover their power and their potential,» said SPIRE Co-managing Director Rich Odell. «The interdisciplinary and experiential options we offer to the student athletes who live on SPIRE’s campus provide multiple ways to help them develop powerful, creative insights—about themselves and others. Our new student housing in SPIRE Village helps create an environment where individuals can not only excel academically but master life’s necessary personal skills so they stand out in their sport or passion and in life in general.»

 

SOURCE SPIRE IA (Institute and Academy)

Acumen Solutions Recognized as Americas Premier Partner of the Year by MuleSoft

MCLEAN, Va., Aug. 5, 2020 /PRNewswire-PRWeb/ — Acumen Solutions today announced it has been named Americas Premier Partner of the Year by MuleSoft, provider of the world’s #1 integration and API platform. Acumen Solutions was recognized for having the greatest market impact in Salesforce’s FY20 based on ACV and practice development in the Americas and its significant contributions to empowering customers. Acumen Solutions provides customers with expertise and best practices as they realize the power…

MCLEAN, Va., Aug. 5, 2020 /PRNewswire-PRWeb/ — Acumen Solutions today announced it has been named Americas Premier Partner of the Year by MuleSoft, provider of the world’s #1 integration and API platform. Acumen Solutions was recognized for having the greatest market impact in Salesforce’s FY20 based on ACV and practice development in the Americas and its significant contributions to empowering customers. Acumen Solutions provides customers with expertise and best practices as they realize the power of API-led connectivity to deliver truly connected customer experiences, faster.

According to the Connectivity Benchmark Report, the average enterprise has data in nearly 900 applications and only one-third are integrated, leading to disconnected customer experiences across channels. Partners like Acumen Solutions are trusted advisors that enable customers to accelerate their digital transformation and deliver connected experiences. MuleSoft partners align against business outcomes, deliver MuleSoft technology, templates and best practices and enable organizations to develop a Center of Enablement that empowers a self-service approach to integration – dramatically increasing the clock speed of business.

As a Salesforce Platinum Partner, Acumen Solutions helps IT shift its focus to adding flexibility and scalability to its integration infrastructure and orchestrations using MuleSoft’s robust cloud and on-premise integration platforms.

«We are proud to be recognized by MuleSoft as the Americas Premier Partner of the Year,» said Eric Pearsall, managing director of global services at Acumen Solutions. «This award highlights our mutual success in the market over the last year and we look forward to continuing to help our clients achieve their goals on the MuleSoft platform for many years to come.»

Leading organizations in the MuleSoft Partner Program provide consulting and services for MuleSoft’s Anypoint Platform™, the world’s #1 integration and API platform. With skills and expertise that leverage API-led connectivity, MuleSoft partners help customers to unlock business capabilities and build application networks that accelerate the speed of IT delivery, increase organizational agility, and enable innovation at scale.

«MuleSoft partners serve as trusted advisors, helping customers adapt to unprecedented change and meet their biggest, most challenging digital transformation projects. Our award winners lead the growing MuleSoft partner ecosystem by prioritizing customer success, leading innovation and growth, and establishing industry best practices that drive the cultural change needed to accelerate digital transformation,» said Brent Hayward, senior vice president of global channels and alliances, MuleSoft. «We look forward to the continued growth of the MuleSoft partner ecosystem and are proud to celebrate the success of our partners as they drive the adoption of application networks and help customers realize new connected experiences.»

To learn more about the MuleSoft Partner Program visit: https://www.mulesoft.com/partner/acumensolutions

About Anypoint Platform
MuleSoft’s Anypoint Platform™ is the world’s #1 integration and API platform. It uniquely allows organizations to use API-led connectivity to unlock their data, empower their business with productized APIs, and create connected experiences, faster. Anypoint Platform is the only solution that offers a single, unified platform for iPaaS and full lifecycle API management, both on-premises and in the cloud.

About Acumen Solutions
Clients choose Acumen Solutions for one simple reason: our experience delivers success. Joining forces with our clients, our team of strategists, subject matter experts, and engineers solve problems that can’t be fixed by technology alone. As a Top 10 Partner of Salesforce, Fortune 500 companies trust us to build solutions that grow revenue and strengthen customer relationships. Our groundbreaking solutions for government and not for profit clients streamline operations and improve productivity. We apply the same expertise to our unparalleled social responsibility program, generating sustainable impact across our local communities. To learn more, visit http://www.acumensolutions.com, or follow us on Twitter @AcumenSolutions.

MuleSoft is a registered trademark of MuleSoft, Inc., a Salesforce company. All other marks are those of respective owners.

 

SOURCE Acumen Solutions

World Teacher and Happy Science Founder Ryuho Okawa Introduces Four Principles of Happiness that Transcends Race and Religion in His New Book «The Laws of Happiness»

NEW YORK, Aug. 5, 2020 /PRNewswire-PRWeb/ — «The Laws of Happiness,» first published in Japan in 2004, the new edited English version will be published on August 28, 2020 by World Teacher and Happy Science founder Ryuho Okawa. «The Laws of Happiness»…

NEW YORK, Aug. 5, 2020 /PRNewswire-PRWeb/ — «The Laws of Happiness,» first published in Japan in 2004, the new edited English version will be published on August 28, 2020 by World Teacher and Happy Science founder Ryuho Okawa. «The Laws of Happiness» represents the «Four Principles of Happiness» which Okawa suggests that all people regardless of their religious or spiritual background should practice in order to pursue true happiness which continues from this world to the next. It is a work in which, as the title suggests, the nature of human happiness is explored at length in a practical and spiritual manner.

Okawa states outright at the beginning of the book that happiness is a decision rather than a quality dependent upon environmental factors. No objective or fixed circumstances can guarantee happiness, and instead happiness is a feeling that is innately generated. Part of the process of learning to be happy exists in accordance with learning from one’s experiences and embracing the reality that each person is given their own «workbook» of problems to which they alone have the answers.

The balance of maintaining happiness along the path of progress in life is explored at length in this work. Okawa states that the seed of unhappiness exists in moments of happiness; in other words, where there are good and successful times, challenging times will inevitably follow as life proceeds onwards. To become aware of this fact during the happy moments is a key to self-improvement whereby one’s weaknesses can be recognized and strengthened in preparation for the future as a means to preventing future unhappiness; all of this requires that one be willing to shed their old self as life progresses. Shortcomings are a positive indication that there is still room for growth all throughout the lifespan.

There are inevitable changes that will occur for all people throughout their life, and adaptations must be made. For example, while younger people benefit from having high energy, they also may suffer from a lack of knowledge and wisdom; as a person ages, they will have less energy but more knowledge, and it is such that changes need not be a source of unhappiness provided one can embrace the opposite strengths that come with ageing. Another example is that a person who is very spiritual benefits from developing practical and worldly insights: whatever the greatest strength a person possesses, they can benefit from developing that which is the opposite of it, and such can be a source of happiness.

Okawa provides a teaching that throughout life each person will gradually see the world through two different eyes: the differentiating eye and the eye of equality. The differentiating eye learns to distinguish the differences between all people and other living things, while the eye of equality learns to see the beauty in that which is common to all things. The former of these allows for the recognition of the individual purposes and roles of all things in the world, while the latter of these allows for the development of compassion and empathy; the continuous development and refinement of these two forms of vision, which Okawa states are the manner in which God views the world, are a key to the path of enlightenment.

There is an extensive discussion in the book concerning finding happiness in work, which is something that many people struggle with. While it is ideal that one works in the area that one is most passionate about, such is not always possible, and when it is not, a change of attitude can bring about happiness even in less than ideal work situations. It is possible, given the limitless potential of humans, to always be working towards improvement in the area of one’s work. Such is accomplished by a combination of factors, and Okawa provides the practical advice of reading to obtain new information, writing one’s thoughts to sort them out, listening to other people in order to learn their thoughts, and thinking in such a manner that one’s thoughts become increasingly developed. Okawa likewise provides several excellent methods for generating and developing new ideas into realities, and emphasizes that ideas which endeavor to contribute toward the collective tend to manifest greater success.

Okawa presents «The Four Principles of Human Happiness,» which are the practice of overcoming suffering through love, wisdom, self-reflection and progress; these may be understood as a contemporary version of Buddhist teachings on enlightenment that are suitable for all modern people. These are explored at depth and with considerable insight that touches upon a combination of spiritual, psychological and environmental factors that impact all people in some way. Some key points include all people want to be loved, no person is 100% perfect, self-reflection is the easiest method to combat negative spiritual influences, and that because one’s thoughts become one’s reality, it is beneficial to concentrate upon positive thoughts in order to manifest a happy life. Ultimately, it is stated that humans benefit the most from seeking the kind of happiness that leads to the happiness of others.

An extensive introduction to Happy Science is provided toward the end of «The Laws of Happiness» and provides an overview of the history and progress of this new religion. It may be stated that «The Laws of Happiness» as a whole is an introduction to the type of limitless, positive and happy thinking that is characteristic of Happy Science. Many of the teachings provided in this work are akin to a modern approach to Buddhist, Christian and other spiritual teachings, and are accessible to all people in the world regardless of their religious background. In a world where all humans desire to be happy and most people struggle to achieve or maintain a state of happiness, «The Laws of Happiness» provides the answers that many are looking for.

«The Laws of Happiness» is available for pre-order at all major bookstores nationwide and online retailers, including Barnes & Noble and Amazon.

IRH Press USA

 

SOURCE Ryuho Okawa

Chemistree Completes Expansion of Sugarleaf Facility

–   Washington State operation grows by about 30%

VANCOUVER, BC, Aug. 5, 2020 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the «Company» or «Chemistree») is pleased to announce that the Washington State Liquor and Cannabis Board («WSLCB») has approved the Company’s expanded facility in Sedro Woolley for cultivation and processing…

–   Washington State operation grows by about 30%

VANCOUVER, BC, Aug. 5, 2020 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the «Company» or «Chemistree») is pleased to announce that the Washington State Liquor and Cannabis Board («WSLCB») has approved the Company’s expanded facility in Sedro Woolley for cultivation and processing operations.  The expansion increases the size of the cultivation area by approximately 30%.

Chemistree commenced construction of the additional grow room in early March, but progress was delayed by the statewide restrictions brought-on by the Covid-19 pandemic.  Management is pleased that the project was completed safely and expeditiously by all the contractors and sub-trades involved; always, keeping workers protected.  The expanded space will now be turned over to the licensee, Sugarleaf for planting and active cannabis operations.

Travis Royce, Sugarleaf’s General Manager stated «Due to our phenomenal crew and practices, our biggest hindrance since day one has been lack of material and growing space. With the WSLCB’s final approval, we now can put our product in more consumers’ hands while simultaneously strengthening our existing client relationships and opening new ones. This is an enormous moment for the Sugarleaf brand and we would absolutely not be in this position without the guidance and support from Chemistree.»

Chemistree President Karl Kottmeier commented, «We have worked together with Sugarleaf to meet their requests for more operating space. I am most grateful that our team has been able to hand over a turnkey expansion customized to their specifications in the midst of a global pandemic.  Washington State is a mature market in the US cannabis industry – and having a larger footprint will benefit Sugarleaf, its retailers and customers for years to come.»

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry.  The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets and to invest in other cannabis-related opportunities, leveraging management’s decades of expertise in the cannabis industry and corporate finance.

For more information, visit www.Chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws
The concepts of «medical cannabis» and «recreational cannabis» do not exist under U.S. federal law. The Federal Controlled Substances Act classifies «marihuana» as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defence to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Prospectus, the Company’s annual information form and other documents incorporated by reference therein and in the Company’s Form 2A listing statement filed with the CSE and available under the Company’s profile on SEDAR at www.sedar.com.

«Karl Kottmeier» 
President

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Information set forth in this news release includes forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as «anticipate», «believe», «plan», «estimate», «expect», «budget», «scheduled» and «intend», statements that an action or event «may», «might», «could», «should», or «will» be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein, without limitation, statements with respect to the expansion and reconfiguration of the Sedro Woolley facility, including the expected increase in the size of the cultivation area, the streamlining of pre- and post-production facilities.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/chemistree-completes-expansion-of-sugarleaf-facility-301106528.html

SOURCE Chemistree Technology Inc.

Blinds.com Expands Cellular Shades Collection to Fit All Window Shapes and Sizes

HOUSTON, Aug. 5, 2020 /PRNewswire-HISPANIC PR WIRE/ — Blinds.com, a Home Depot company, announces an expansion to its popular cellular shades collection to feature a complete, integrated system that is designed to cover any type of window in the home.

<img id="prnejpg9fbbleft" title=" " border="0" alt=" " align="middle" imagelabel="General"…

HOUSTON, Aug. 5, 2020 /PRNewswire-HISPANIC PR WIRE/ — Blinds.com, a Home Depot company, announces an expansion to its popular cellular shades collection to feature a complete, integrated system that is designed to cover any type of window in the home.

With this new expansion of the Blinds.com Cellular Shades Collection, customers can choose from the most extensive upgrade selection offered by Blinds.com. Suited for not only traditional windows, these upgradeable and customizable cellular shades are an ideal choice for difficult-to-reach windows, homes with children or pets, or oddly shaped windows such as perfect arches or French doors.

«We’re doing the hard work for our customers to make it easy for them to treat all their windows at once,» says Amber Hall, vice president of merchandising at Blinds.com. «This isn’t just one single new upgrade option or a new color to choose from. This new cellular shade expansion represents a unified ecosystem of our most extensive and flexible upgrades.»

ONE STYLE FITS ALL

In the past, specialty windows required different products to fit various sizes and shapes, potentially resulting in a mismatched color selection. This latest cellular shade innovation makes it easy to treat not only standard windows, but also arched windows, skylights, patio doors, and French doors.

For example, French doors were previously difficult to hold window treatments due to the obstruction of door handles and minimum depth requirements. For the first time ever, Blinds.com now offers a cellular shade upgrade specifically designed to treat French door windows. With the French door upgrade, your cellular shades will fit neatly into a small frame that hides the operating mechanisms and holds the shades close to the door, eliminating the awkward swinging previously seen when treating French door windows.

WINDOW TREATMENT UPGRADES FOR ANY HOME

It has never been easier to outfit window treatments to exact needs and specifications. Upgrading cellular shades with customizable options can enhance any lifestyle or room.

As one of the most popular window treatment upgrades, motorized shades provide the ultimate in convenience, allowing you to raise or lower your cellular shades with just the press of a button. Motorized cellular shades are a great fit for media rooms to eliminate unwanted glare, or bedrooms to block the early sun. They’re also cordless, making them a safer choice for homes with children or pets.

Customers can also enjoy the benefits of cordless operation without motorization. A cordless lift enhances a room’s appearance by eliminating the visual distraction of unsightly cords, leaving windows with clear, unobstructed views.

This new expansion features these additional optional upgrades:

  • Continuous Cord Loop
  • Top Down/Bottom Up
  • 2/1 Headrail
  • Opacities from Light-Filtering to Blackout
  • Smart Release
  • XL Pleat Sizes
  • Double or Single Cell

RAINBOW OF COLORS

In addition to new upgrades, this latest expansion of cellular shades features a stunning array of new color options. Inspired by natural beauty, these new cellular shades can make a bold stylistic choice or subtly complement your favorite piece of furniture.

From botanical colors such as carnation, chamomile and spearmint to warm and cool options such as frost, candlelight and Baltic blue, this vast selection of fresh colors touches every shade of the spectrum.

The new cellular shades expansion also takes curb appeal into consideration. No matter which color you choose, the sides of the shades facing the street will all be the same neutral color, meaning that mismatched windows will no longer be seen from the outside.

GET THE LOOK

For more window treatment inspiration and expert information, read the Blinds.com Cellular Shade Buying Guide, How to Measure for Cellular Shades, and How to Install Cellular Shades.

About Blinds.com: Blinds.com is part of The Home Depot’s industry-leading family of brands, and the largest eCommerce retailer of window coverings in the world – covering over a million windows a year since 1996. Blinds.com makes ordering custom blinds, shades, shutters, and draperies surprisingly easy with over 30,000 five-star reviews, award-winning customer service, SureFit Guarantee, and in-home measure and installation services. Shop online at Blinds.com or call 1-866-647-2526 to speak to one of 200+ blinds experts.

Logo – https://mma.prnewswire.com/media/1223926/blinds_Logo.jpg

SOURCE Blinds.com

IDTechEx: AI Accelerates Materials Science From the Lab to Market

BOSTON, Aug. 5, 2020 /PRNewswire/ — Nearly every sector is proposing the use of artificial intelligence. Materials science R&D is relatively late to this trend, and there are many industry-specific hurdles, but the opportunities are beginning to be realized and the potential impact is significant.

BOSTON, Aug. 5, 2020 /PRNewswire/ — Nearly every sector is proposing the use of artificial intelligence. Materials science R&D is relatively late to this trend, and there are many industry-specific hurdles, but the opportunities are beginning to be realized and the potential impact is significant.

Materials informatics is the use of data-centric approaches for materials science discovery and development. This is principally enabled by improved data infrastructures and machine learning solutions; this is set to be a paradigm shift in the way researchers conduct R&D projects and a discussion on why the adoption is now can be seen in a previous article. At this key moment of initial commercial adoption, IDTechEx has released the most comprehensive technical market report on the topic, «Materials Informatics 2020-2030«.

Materials informatics can be used at every stage of an experimental process as outlined in the infographic below. There are multiple potential advantages including identifying new species or relationships, extracting value from existing data, and generating use-case IP on existing compounds, but in most cases it is all about accelerating the time to market and providing a competitive advantage.

Quantifying this accelerated time to market is difficult but essential for external companies to demonstrate and justify any investment. Many claim extensive examples of reducing millions of candidates and/or thousands of experiments to more manageable hundreds, or even tens, of solutions or iterations.

IDTechEx has classified the projects undertaken into 6 main categories outlined in detail within the report. Previous articles have shown how this has been used in multiple applications already.

A key concept is the idea of an «inverse design». In simple terms, this can involve training a model that allows properties to be input and formulations, compositions, process parameters or more to be proposed. The properties do not have to just be physical but could also be cost, toxicity, geographic availability or more. The technology is applicable to anyone that designs materials or designs with materials, an aim is to have this inverse design fully integrated with initial product design. This has been most effectively shown by the collaboration between Citrine Informatics and Siemens. It was stated that they want designers to view material as one of their «degrees of freedom» and allow materials companies to become «partners not vendors».

For clarity, materials informatics is not to be confused with computational simulation (e.g. DFT calculations). This material modeling has seen major progressions over the past few decades (led by the likes of BIOVIA and Schrödinger) and with the continual improvement in computing power this will only increase. The announcement between JSR Corporation and QSimulate is notable recent evidence towards this. The data can be used in the same way as input data from any physical experimentation. In fact, a common approach of MI is used in reducing the number of costly and time-consuming simulations, facilitating these research projects, and drawing novel relationships.

The main problem is the limitations of the materials dataset. This is not like recognizing objects in autonomous vehicles or sophisticated internet search engines, materials science brings numerous specific problems. The data is typically sparse, high-dimensional, biased, and noisy which means that understanding the uncertainty in the proposed output is essential; projecting out into the «unknown» is very challenging given the clustered, complex data.

There are many approaches to dealing with small datasets, this could involve generating one through high-throughput experimentation, leveraging external data repositories and most importantly integrating domain knowledge.

Generating and leveraging data repositories is a core theme of materials informatics. There are a wide number of very bespoke or more general repositories collecting published structures, properties, and other data. These are run by public or private organizations and, although may have limitations (such as unknown confidence in the data and biased by only having «positive» published results), they can be an unparalleled source for training models or screening for candidates. Not to mention large datasets opens the opportunity for utilizing more sophisticated deep learning methods.

Accelerating the time from materials design to market is essential. The material development cycle is normally far slower than many end-user products and in certain sectors this development and qualification can be the bottleneck. Materials informatics can change that. For more information on this market see the IDTechEx report, «Materials Informatics 2020-2030», www.IDTechEx.com/MaterialsInformatics.

IDTechEx also covers many of the relevant application areas highlighted throughout the report, for deeper-dive in each of these markets including additive manufacturing, graphene & other nanomaterials, energy storage, organic electronics, wearable electronics, sensors and more visit www.IDTechEx.com/research.

IDTechEx guides your strategic business decisions through its Research, Consultancy and Event products, helping you profit from emerging technologies. For more information on IDTechEx Research and Consultancy, contact research@IDTechEx.com or visit www.IDTechEx.com.

Media Contact:
Natalie Moreton
Digital Marketing Manager
press@IDTechEx.com
+44(0)1223 812300

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/idtechex-ai-accelerates-materials-science-from-the-lab-to-market-301106561.html

SOURCE IDTechEx

Automotive Sensors Market worth $40.3 billion by 2025 – Exclusive Report by MarketsandMarkets™

CHICAGO, Aug. 5, 2020 /PRNewswire/ — According to the new market research report «Automotive Sensors Market by Type (Temperature, Pressure, Position, Oxygen, NOx, Speed, Inertial, Image), Application (Powertrain, Chassis, Safety & Control, Telematics), Vehicle Type, Sales Channel, Region – Global Forecast to 2025″, published by MarketsandMarkets™, the Automotive Sensors Market is projected to reach USD 40.3 billion by 2025 from an estimated <span…

CHICAGO, Aug. 5, 2020 /PRNewswire/ — According to the new market research report «Automotive Sensors Market by Type (Temperature, Pressure, Position, Oxygen, NOx, Speed, Inertial, Image), Application (Powertrain, Chassis, Safety & Control, Telematics), Vehicle Type, Sales Channel, Region – Global Forecast to 2025″, published by MarketsandMarkets™, the Automotive Sensors Market is projected to reach USD 40.3 billion by 2025 from an estimated USD 24.5 billion in 2020, it is expected to grow at a CAGR of 10.5% from 2020 to 2025. Increased global motor vehicle production, rise in demand for vehicle electrification, formulation of stringent government regulations related to emissions, and an increase in consumer demand for safety and comfort in vehicles are the major factors driving the growth of the automotive sensors market. Increasing demand for advanced driver-assistance systems (ADAS) and ongoing rapid developments in autonomous cars present growth opportunities for the automotive sensors market.

MarketsandMarkets_Logo

Ask for PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=426    

Based on type, the image sensors segment of the automotive sensors market is projected to grow at the highest CAGR from 2020 and 2025.

Based on type, the automotive sensors market has been segmented into position sensors, speed sensors, pressure sensors, oxygen sensors, NOx sensors, inertial sensors, temperature sensors, image sensors, and other sensors. Among all these, the image sensors segment is projected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increased demand for image sensors used in ADAS, active parking assistance (APA) systems, lane departure warning (LDW) systems, collision avoidance systems, and other safety systems. The rapid development of autonomous cars, which rely significantly on image sensors, has also spiked the global demand for image sensors.

Based on application, the safety and control segment of the automotive sensors market is projected to grow at the highest CAGR during the forecast period.

The automotive sensors market has been segmented into powertrain, chassis, body electronics, safety & control, exhaust, telematics, and others. The government regulations pertaining to vehicle safety, rise in demand for safe, efficient, and convenient driving experience, and increasing demand for luxury cars are some of the factors driving the growth of the automotive sensors market for safety & control applications. The advent of autonomous cars and growing demand for electric vehicles would further create opportunities for the automotive sensors market for safety & control applications.

Browse in-depth TOC on «Automotive Sensors Market«

239 – Tables
77 – Figures
249 – Pages         

Inquiry Before Buying:

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=426

The automotive sensors market in APAC is projected to grow at the highest CAGR from 2019 to 2025.

The automotive sensors market has been studied for North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). The increasing purchasing power of consumers and the rising demand for highly efficient and safe vehicles are the main factors driving the growth of the automotive sensors market in APAC. Emerging economies such as India and China are major contributors to the growth of the automotive sensors market in this region. China is leading the global automobile production, and it is expected to continue leading this production during the forecast period as well. The Government of the People’s Republic of China emphasizes the promotion and adoption of energy-efficient plug-in hybrid electric vehicles (EVs) and pure EVs.

Robert Bosch (Germany), Continental AG (Germany), Delphi Automotive (UK), Denso Corporation (Japan), Infineon Technologies (Germany), Sensata Technologies (US), Allegro Microsystems (US), Analog Devices (US), Elmos Semiconductor (Germany), CTS Corporation (US), Autoliv Inc. (Sweden), NXP Semiconductor (Netherlands), TE Connectivity (Switzerland), STMicroelectronics(Switzerland), ON Semiconductor (US), Melexis (Belgium), ZF Friedrichshafen AG (Germany), Quanergy (US), Innoviz Technologies (Israel), and Velodyne LiDAR (US) are some of the key players in the automotive sensors market.

Related Reports:             

Temperature Sensor Market by Product Type (Thermocouples, RTDs, Thermistors, Temperature Sensor ICs, Bimetallic, Infrared, and Fiber Optic Temperature Sensors), Output, End-user Industry, and Region – Global Forecast to 2027

Gas Sensors Market by Gas Type (Oxygen, Carbon Monoxide, Carbon Dioxide, Ammonia, Chlorine, Hydrogen Sulfide, Nitrogen Oxide, Volatile Organic Compounds, Hydrocarbons), Technology, Application, Geography – Global Forecast 2024

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the «Growth Engagement Model – GEM». The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write «Attack, avoid and defend» strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, «Knowledge Store» connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Web Site: https://www.marketsandmarkets.com
Research Insight : https://www.marketsandmarkets.com/ResearchInsight/automotive-sensors-market.asp 
Content Source : https://www.marketsandmarkets.com/PressReleases/automotive-sensor.asp 

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

 

Elios Therapeutics Personalized Cancer Vaccine Demonstrates Long-Term Survival Benefit Among High-Risk Melanoma Patients in Phase IIb Final Analysis

AUSTIN, Texas, Aug. 5, 2020 /PRNewswire/ — Elios Therapeutics, a biopharmaceutical company developing innovative personalized therapeutic cancer vaccines, today announced final data from a prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial evaluating adjuvant use of its personalized tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with Stage III or Stage IV melanoma at high risk of recurrence following complete surgical resection.

AUSTIN, Texas, Aug. 5, 2020 /PRNewswire/ — Elios Therapeutics, a biopharmaceutical company developing innovative personalized therapeutic cancer vaccines, today announced final data from a prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial evaluating adjuvant use of its personalized tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with Stage III or Stage IV melanoma at high risk of recurrence following complete surgical resection.

«We now have long-term data demonstrating that use of the TLPLDC vaccine for the adjuvant treatment of high-risk melanoma correlates with a 93 percent increase in patients alive at three years without their disease returning. This trial also significantly improves our understanding of the optimal method of vaccine production,» said Buddy Long, chief executive officer of Elios Therapeutics. «These new data, combined with the doubled rate of disease-free survival among patients treated with the vaccine and standard of care checkpoint inhibitors, further strengthen our confidence that the personalized TLPLDC vaccine provides a clinically meaningful benefit for people with high-risk melanoma. We look forward to advancing this vaccine with a registrational Phase III trial that will move us one step closer to bringing this important treatment to patients as soon as possible.»

The TLPLDC vaccine is a personalized treatment that is created using a patient’s own blood and tumor cells. Samples are collected at resection, frozen, and sent to the lab where they are used to create autologous tumor lysate, which is loaded into yeast cell wall particles. This combination is then introduced to the patient’s dendritic cells, leading to the creation of the final TLPLDC vaccine. The time from resection to injection of the vaccine takes approximately three weeks.

The vaccine has been studied in a large randomized Phase IIb trial, and the newly reported data is from the pre-specified 36-month disease-free survival (DFS) and overall survival (OS) assessment by vaccine formulation, stage, and checkpoint inhibition. The analysis included all randomized patients in an intent-to-treat (ITT) analysis. Two versions of the vaccine, one produced by isolating dendritic cells (DCs) from 120 mL of blood (vaccine-A) and one with DCs isolated after a single injection of filgrastim followed by 50-70 mL of blood (vaccine-B), were tested in 144 participants who were randomized to receive either version of the vaccine or placebo to prevent recurrence.

A key finding showed that treatment with vaccine-B resulted in clinical outcomes similar to placebo. Producing the vaccine with filgrastim was intended to increase white blood cell and dendritic cell counts, requiring less blood to be drawn from patients to create the vaccine. While the use of filgrastim increased DC production, it takes only 72-hours to create the vaccine which was not enough time for the DCs to mature, rendering vaccine-B ineffective. 

Importantly, vaccine-A, when compared to vaccine-B and placebo, resulted in a statistically significant improvement in 36-month DFS (51.8% vs. 23.4% vs 27.1%, respectively; p=0.027) and OS (92.9% vs. 62.8% vs 70.3%, respectively; p=0.022) in the ITT population.

Furthermore, the DFS improvement with vaccine-A was seen across both Stage III (49.7% vs. 29.4%; p=0.066) and IV (68.6% vs. 9.4%; p=0.0582) patients. Importantly, the addition of vaccine-A to current standard of care checkpoint inhibitors led to a statistically significant increase in 36-month DFS in the ITT population compared to treatment with checkpoint inhibitors alone (48.5% vs. 24.1%; p=0.039). As previously reported, treatment with the vaccine was well-tolerated with 34.7 percent of patients experiencing a treatment-related adverse event, and >90% being grades 1 or 2.

«To demonstrate a long-term survival benefit with low toxicity in a therapeutic is what we hope for in every clinical trial. Achieving this with an aggressive disease like melanoma offers great promise for patients,» said Mark B. Faries, M.D., co-director of the Melanoma Program and head of Surgical Oncology at Cedars-Sinai at The Angeles Clinic and Research Institute, and principal investigator of the study. «With data showing a two-fold increase in disease-free survival with the vaccine alone and in combination with checkpoint inhibitors, we hope to one day change the narrative for people with melanoma – turning this disease into a chronic condition that can be treated and managed over time.»           

About Melanoma
Melanoma is more likely to grow and spread than other types of skin cancer. When diagnosed and treated at an early stage, melanoma has a high cure rate, however patients with later stages of the disease carry a high risk for melanoma recurrence because some melanoma cells can remain in the body, even after surgery. In the U.S, the incidence of melanoma has increased over the past decades, with 91,270 estimated new cases and 9,320 related deaths in 2018. 

About the Phase IIb TLPLDC Study
This Phase IIb study is a prospective, randomized, double-blind, placebo-controlled trial designed to evaluate the safety and efficacy of the TLPLDC (tumor lysate, particle-loaded, dendritic cell) vaccine in patients with resected Stage III and IV melanoma. The primary endpoint of the trial is two-year disease-free survival (DFS), and the secondary endpoint is three-year DFS and overall survival (OS).

In the study, 144 participants were randomized to receive either the vaccine or placebo to prevent recurrence. TLPLDC or placebo vaccines were initiated within three months of completion of standard of care (SoC) therapies and were given at 0, 1, 2, 6, 12, and 18 months. The protocol was amended to allow concurrent checkpoint inhibitor therapy once approved for the adjuvant setting. Study participants were followed for recurrence per SoC. The primary efficacy analysis was performed on the intent-to-treat (ITT) and the per treatment (PT) populations as co-primary analyses given the high early recurrence rate often seen in patients with advanced melanoma. Secondary endpoints include 36-month DFS and overall survival (OS) which will be compared between the vaccinated and control groups as well as by vaccine formulation.

About TLPLDC
The TLPLDC (tumor lysate, particle-loaded, dendritic cell) vaccine is a unique type of immunotherapy, both in how it is made and how it is delivered. The vaccine is personalized, meaning it is made from a patient’s tumor and blood. Every patient’s tumor has a unique antigenic profile unlike any other, and dendritic cells found in the blood are the most potent antigen-presenting cells in the body. Once TLPLDC is administered, it delivers the patient’s complete repertoire of tumor antigens to the immune system, creating a dual innate and adaptive immune response, activating fighter T cells, and triggering the immune system to recognize, and seek out and destroy any cells containing the antigens and specific mutations from their tumor. 

Historically, autologous cancer vaccines have been rather onerous to develop, sometimes taking months between the tumor biopsy and administration. Elios has simplified the process so the time from resection to injection is approximately two weeks. This makes the vaccine highly feasible and will ultimately be easy for community and academic oncologists to adopt into their practices.

The TLPLDC vaccine is currently being studied as a monotherapy and in combination with standard-of-care checkpoint inhibitor therapies in a Phase IIb clinical trial for the treatment of late-stage melanoma at leading academic cancer centers in the United States.

About Elios Therapeutics, LLC
Elios Therapeutics, LLC, a wholly owned subsidiary of Perseus Holdings, LLC., is a biopharmaceutical company developing a portfolio of innovative personalized therapeutic cancer vaccines targeting unmet medical needs across a broad range of tumor types. Elios’ lead therapeutic candidate is the TLPLDC (tumor lysate, particle-loaded, dendritic cell) vaccine, a personalized therapeutic cancer vaccine that uses a proprietary particle delivery system to stimulate the body’s immune system to recognize cancer cells as foreign pathogens and fight a patient’s specific cancer. For more information, please visit www.eliostherapeutics.com.

Forward-Looking Statements
This document contains forward–looking statements relating to the Company’s strategy, objectives, business development plans and financial position. All statements other than statements of historical facts included in this document, including, without limitation, statements regarding the Company’s future financial position, strategy, anticipated investments, costs and results, status and results of clinical trials, size of patient population, plans, outcomes of product development efforts, and objectives of management for future operations, may be deemed to be forward–looking statements. You can identify forward-looking statements by words such as «anticipate,» «believe,» «could,» «estimate,» «expect,» «intend,» «may,» «plan,» «potential,» «predict,» «project,» «should,» «will,» «would,» or the negative of those terms, and similar expressions that convey uncertainty or future events or outcomes. These forward–looking statements involve known and unknown risks, uncertainties, and other factors that may cause the Company’s actual results, performance, or achievements or industry results to be materially different from those contemplated, projected, forecasted, estimated or budgeted, whether expressed or implied, by these forward–looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward–looking statements as a prediction of actual results. None of these forward–looking statements constitutes a guarantee of the future occurrence of such events or of actual results. These statements are based on data, assumptions, and estimates that the Company believes are reasonable. The forward–looking statements contained in this document are made only as of the date hereof. Except as otherwise required by law, the Company expressly disclaims any obligation or undertaking to release publicly any updates of any forward-looking statements contained in this document to reflect any change in its actual results, assumptions, expectations or any change in events, factors, conditions, or circumstances on which any forward–looking statement contained in this document is based.

Contacts:

Media Relations
Vikki Christian 
Elixir Health Public Relations
+1 (424) 610-1241
vchristian@elixirhealthpr.com

1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68:7–30_Accessed at: https://www.ncbi.nlm.nih.gov/pubmed/29313949

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/elios-therapeutics-personalized-cancer-vaccine-demonstrates-long-term-survival-benefit-among-high-risk-melanoma-patients-in-phase-iib-final-analysis-301106313.html

SOURCE Elios Therapeutics, LLC; Perseus Holdings USA

TE Connectivity sets new sustainability, charitable goals for 2030

SCHAUFFHAUSEN, Switzerland, Aug. 5, 2020 /PRNewswire/ — TE Connectivity (NYSE: TEL), a world leader in connectivity and sensors, today unveiled a long-term sustainability and corporate responsibility strategy to better focus on the company’s vision for the future.

SCHAUFFHAUSEN, Switzerland, Aug. 5, 2020 /PRNewswire/ — TE Connectivity (NYSE: TEL), a world leader in connectivity and sensors, today unveiled a long-term sustainability and corporate responsibility strategy to better focus on the company’s vision for the future.

TE’s One Connected World strategy details a series of goals to make the world a better place as the company serves its employees, customers and shareholders.

«At TE, we have had an ongoing and transparent record of environmental, social and governance reporting through our annual corporate responsibility report and I’m proud of our progress over the past 10 years,» said CEO Terrence Curtin. «Now, we are evolving our strategy to the next level with One Connected World, which builds on our purpose of creating a safer, sustainable, productive and connected future and provides a roadmap for us to make a measurable impact over the next decade.»

TE has set nine strategic goals to meet by 2030:

  • Embed sustainability in product creation at TE
  • Partner with our direct and logistics suppliers to strengthen the sustainability of our supply chain; align our new construction with the Sustainable Facility Initiative
  • Zero-accident workplace
  • 100% of facilities in water-scarce locations meet reduction targets
  • Decrease waste disposed
  • 35%+ reduction in greenhouse gas emissions
  • Strengthen our workplace culture, in which all differences are valued and all opinions count
  • Impact 3 million people in next-generation technology education
  • Implement a global human rights program

The company will measure its progress toward these goals and report out annually in its corporate responsibility report starting with the FY2020 report. Some of the work TE already does in pursuit of its vision of One Connected World is detailed in the FY2019 report. As one example, the report showcases how TE has incorporated sustainability into its operations over the past decade. The company has met greenhouse gas and energy reduction goals in 2012, 2015 and 2018.

This report also marks the first year TE’s corporate responsibility report aligns with the Sustainability Accounting Standards Board (SASB) standards. TE reports to the SASB standard specific to its industry as identified in the Sustainable Industry Classification System® (SICS®): Resource Transformation Sector — Electrical & Electronic Equipment Sustainability Accounting Standard.

To view the full FY2019 corporate responsibility report, visit TE.com/responsibility.

ABOUT TE CONNECTIVITY

TE Connectivity (NYSE: TEL) is a $13 billion global industrial technology leader creating a safer, sustainable, productive, and connected future. Our broad range of connectivity and sensor solutions, proven in the harshest environments, enable advancements in transportation, industrial applications, medical technology, energy, data communications, and the home. With nearly 80,000 employees, including more than 8,000 engineers, working alongside customers in approximately 150 countries, TE ensures that EVERY CONNECTION COUNTS. Learn more at www.te.com and on LinkedIn, Facebook, WeChat and Twitter.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/te-connectivity-sets-new-sustainability-charitable-goals-for-2030-301106378.html

SOURCE TE Connectivity Ltd.